Fluidigm Taps Former Instrument Executive to be CTO | GenomeWeb

NEW YORK, Aug. 7 – Microfluidics startup Fluidigm has appointed Douglas Modlin to the position of chief technology officer and vice president of research and development, the company said on Tuesday.  

Modlin previously served as vice president of instrumentation technology research and development at Molecular Devices Corporation. He has also worked in various capacities at LJL BioSystems, Affymax, and Affymetrix.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."